Observational
Conditions
Keywords
Angina, Chest pain, Diagnostic tests
Brief summary
A prospective, blinded multicenter study for evaluation of chest pain patients with severe coronary calcium (Agatston score \> 399). The objective is to evaluate if an initial non-invasive strategy with coronary computed tomography angiography (CCTA) including functional flow reserve derived from CCTA (FFR-CT) is as effective as invasive coronary angiography (ICA) including functional flow reserve (FFR) for the detection and exclusion of obstructive coronary artery disease (CAD). Study hypothesis: initial non-invasive anatomic and functional testing is non-inferior to an invasive anatomic and functional testing strategy.
Detailed description
Prospective, blinded multicenter study evaluating the diagnostic performance of coronary computed tomography angiography (CCTA) including functional flow reserve derived from CCTA (FFR-CT) for the detection and exclusion of significant obstructive coronary artery disease (CAD). The reference standard vil be invasive coronary angiography (ICA) including functional flow reserve (FFR). Patients referred for elective CCTA because of suspected stable CAD are considered. If the initial routine non-enhanced CT scan shows an Agatston score \> 399, the patient is eligible for study inclusion. Four sites in the region of Southern Denmark will participate (Odense University Hospital, Svendborg Hospital, Vejle Hospital and Esbjerg Hospital). A total of 278 patients will be included.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Age ≥ 18 years * An estimated likelihood for the presence of significant CAD between 15% and 85% * Clinical stable patients with symptoms of suspected CAD referred for CTTA * Initial routine non-enhanced CT scan shows an Agatston score \>399 * Written informed consent * Accept to undergo elective invasive coronary angiography (ICA) within 90 days
Exclusion criteria
* Known prior myocardial infarction * Prior percutaneous coronary intervention (PCI) * Prior coronary artery bypass surgery (CABG) * Pacemaker or internal defibrillator lead implantation * Prosthetic heart valve * Atrial fibrillation * Renal Insufficiency (\<40 mL/min) * Known anaphylactic reaction to iodinated contrast * Pregnancy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Per-patient diagnostic accuracy of functional flow reserve (FFR-CT) derived from standard coronary computed tomography angiography (CCTA) compared to invasive coronary angiography (ICA) including functional flow ratio (FFR) | Comparison of the noninvasive and invasive diagnostic modalities is performed at least 90 days after enrollment of each of the included patients | The primary outcome measure is the per-patient diagnostic accuracy of functional flow reserve (FFR-CT) derived from standard coronary computed tomography angiography (CCTA) compared to invasive coronary angiography (ICA) including functional flow ratio (FFR), which is considered the gold standard in the detection or exclusion of obstructive coronary artery disease (CAD) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Coronary revascularization procedures | 90 day after inclusion | Percentage of coronary revascularization procedures (PCI and CABG) in patients with reduced FFR-CT vs. patients with normal FFR-CT |
| Other clinical endpoints | 90 days after inclusion | Percentage of patients with the composite endpoint of all-cause mortality or myocardial infarction or unstable angina hospitalization |
| Major complications from diagnostic invasive diagnostic procedures | Within 72 hours after invasive procedure | Percentage of patients with major complications following invasive coronary angiography (ICA) including fractional flow reserve (FFR) measurement |
| Invasive coronary angiography (ICA) including functional flow ratio (FFR) without obstructive coronary artery disease | 90 days after inclusion | Percentage of patients with invasive coronary angiography (ICA) including functional flow reserve (FFR) measurement without evidence of obstructive coronary artery disease |
| Per-vessel correlation of FFR-CT numerical value with the FFR numerical value in patients undergoing FFR | At least 90 days after patient inclusion | The per-vessel correlation of FFRCT numerical value with the FFR numerical value in patients undergoing FFR |
| The diagnostic accuracy of FFR-CT in subgroups of patients with high calcium score vs. patients with very high calcium score | At least 90 days after patient inclusion | Comparison of the diagnostic accuracy of FFR-CT in subgroups of patients with high calcium score (Agatston score 400-999) vs patients with very high calcium score (Agatston score ≥ 999) |
| Costs and resource use. | 90 days after inclusion | Estimating the total costs of potentially unnecessary invasive coronary angiographies with functional flow ratio measurements |
| Per-patient and per-vessel diagnostic performance of FFR-CT by means of accuracy, sensitivity, specificity, positive predictive value, and negative predictive value | At least 90 days after patient inclusion | Assessing per-patient and per-vessel diagnostic performance of FFR-CT by means of accuracy, sensitivity, specificity, positive predictive value, and negative predictive value |
Countries
Denmark